Murli Krishna Pharma Pvt. Ltd.

Murli Krishna Pharma Private Ltd is a young and dynamic drug delivery systems (DDS) company in India that provides a range of effective solutions to optimize the delivery of pharmaceutical products.

Murli Krishna Pharma is an R&D-driven organization that offers a complete range of oral delivery technologies including :
Controlled and Delayed Release Matrix
Multiparticulate Deliveries
Extended Release Technologies

1. Murli Krishna Pharma Pvt. Ltd.
Innovative Solutions for Oral Dosage
Forms…..

Factory :
D-98, Ranjangaon, M.I.D.C., Ranjangaon, Taluka-Shirur, District – Pune, 412209
– Maharashtra.
TEL.:[phone],660772. Fax: [phone].
Cop. Office:
No. 8, Pearl Bldg., Powai Vihar Complex, A.S.Marg, Powai, Mumbai – 400 076.
India.
Tel. : [phone]/3598/Fax : [phone].
Email: [email protected] Web Site: www.mkppl.com

……….we turn ideas into technology

2. Company Profile
•MKPPL is a Research based company manufacturing high value
drug products in the form of Enteric Coated Pellets.
•European GMP certified plant for Omeprazole pellets
•100% Export Oriented Unit (EOU)
•Single stop for Coating Solutions
•Commercial Production started in October 2005
•Compliance with regulatory standards – Both Indian and
International

3. Vision
•Turning Technology dreams into reality.
Mission
•Become a Global Pharmaceutical export company
•Continuing the development of Aqueous based Coating Techniques .
•Extending our expertise in designing Solid Dosage forms for Stents moving
from the current Micro Encapsulation to Nano Encapsulation Using
Aqueous Dispersion Techniques.
•Focusing on New and Novel Drug Deliveries with an eye on Patents

4. Our Strengths
•Right products
•Right people
•Right infrastructure
•Right environment
•Deliver quality product on time at competitive price
•Right quality procedures in practice

5. Right Products
*Patent non infringing *Patent non infringing
Product Strength Pellet
Size
Category
Omeprazole Pellets 8.5%,10 % 14#18
16#20
Anti-ulcerant
Lansoprazole Pellets 8.5% 14#18
24#30
Anti-ulcerant
Itraconazole Pellets 22% 14#18 Anti-ulcerant
Esomeprazole Pellets 8.5% &
22.5%,22%
14#18
16#20
Anti-ulcerant
Pantoprazole Pellets 15% ,22% 14#18 Anti-ulcerant
Tacrolimus Pellets0.5%, 1% & 5%--- Immune-Suppressant
Clarithromycin Pellets40% 20#30 Macrolide
Orlistat Pellets 50% -- Anti-obesity
Mesalazine Pellets 70% ---- Anti-ulcerant

6. Right Products
New Molecules in pipeline
•Rapamycin (Sirolimus) Pellets 0.5%, 1%, 5%
•Mycophenolate Mofitil Pellets 50%
•Paclitaxel Pellets 25%, 50%
•Azithromycin Pellets 40%
We have a dedicated manufacturing facility for Immune-Suppressant
Pellets
Total Plant Capacity at present : 12 MT Per Month

7. Advantage in using Enteric coated pellets
Manufactured by MKPPL
•Ready to fill any size of capsules.
•No processing prior to capsule and dry syrup filling resulting.
in substantial cost and time saving.
•Easy to make dry syrup for children.
•No organic solvents used during coating or at any other stage
of manufacturing.
•Better in-vitro and in-vivo absorption profile (matching with
innovators profile) for long term Pharmacological action

8. Right people
Experienced work force and management team
Department M.PharmB.PharmM.ScB.Sc/B.EB.ComM.Com/
M.A
D.Pharm/D.EOtherTotal
Production 0 3 1 3 0 0 2 6 15
Quality
Assurance
3
5 1 2 0 0 0 0 11
Quality Control 0 3 6 1 0 0 2 0 12
Warehouse 0 0 0 1 1 0 0 3 5
Engineering 0 0 0 0 0 0 1 7 8
Human
Resources
0 0 0 0 0 2 0 0 2
Administration 0 0 0 0 0 1 1 2 5
Product
Development
Lab.
4 1 1 0 0 0 0 1 7
I.T. 0 0 0 1 0 0 0 0 1
Total 66

9. ORGANOGRAM
Director Administration
Mrs. Sitamahalakshmi
Challa
Technical Director
Dr. Vijay K. Shastri
GM
Manufacturing
Operations
Mr. A. V.
Kulkarni
Logistics
CMD
Mrs. Satya R. Vadlamani
Purchase
FDA Liaison
Mr. K. V. Narale
Chief Finance Officer
Mr. R. V. Ranjan
Director Business Development &
Technical Services
Dr. Pramod P. Karkhanis
Material Management
& Procurement
Material
Inventory
Control
&
Product
Inventory
Control
DGM QC
Ms. Sushila Kumari
Human
Resources
Global Business
Development, Global
Regulatory Compliance
Ms.Tahera Dashti
Head Process
Development
Laboratory
Mr. T.
Phanikumar
Research
&
Development
Head Accounts
Department
Ms. S. S. More
GM Quality
Assurance &
Regulatory Affairs
Mr. R. B. Patil
DGM Quality
Assurance &
Regulatory
compliance
Mr.S.B.Bhalekar
Mr. S. B. Bhalekar
Manager
Engineering &
Maintenance
Mr. D. M. Deshmukh
Senior DGM Production
Material Handling, Store ,
Dispatch, Distribution.
Mr. T.K.Halande
Asst.Mgr. QA&RA
Ms.Kavita Godase

10. Management Team
•Mrs. Satya Vadlamani
Chairperson and Managing Director
•Dr. Vijay K Shastri
Director-Technical
•Dr.Pramod P. Karkhanis
Director-Business Development and Technical Services.
•Mrs. C. Sitamahalaxmi
Director – Administration
•Mr. Ranjan
CFO- Finance

11. Our Partners in Venture
•Rhenochem AG- Switzerland

Equity holders as well as marketing partners in Europe and
South America
•Elcon Hongkong Ltd.---Hongkong

Equity holders as well as marketing represntatives in China

12. Our clientele
European USA
•Medichrom — Greece
•Farmoz — Portugal
•Slavia Pharm — Romania
•Welding Gmbh — Germany
•Rhenochem AG – Switzerland
•Karieb Kemi – UK
•Mylan Inc.
•Cutis Pharma Inc.
•Cogentus
Pharmaceuticals Inc.
•Geo Pharma Inc.
•Neuromoleculuar
Synthesis

13. Thank You!